SCPHARMACEUTICALS INC's ticker is SCPH and the CUSIP is 810648105. A total of 47 filers reported holding SCPHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37 | -36.2% | 5,122 | -11.0% | 0.00% | – |
| Q2 2023 | $58 | -91.3% | 5,756 | -92.2% | 0.00% | – |
| Q1 2023 | $666 | -86.7% | 73,448 | +8923.1% | 0.00% | – |
| Q3 2021 | $5,000 | 0.0% | 814 | +5.7% | 0.00% | – |
| Q2 2021 | $5,000 | -87.2% | 770 | -86.8% | 0.00% | – |
| Q1 2021 | $39,000 | +225.0% | 5,849 | +159.0% | 0.00% | – |
| Q4 2020 | $12,000 | -50.0% | 2,258 | -27.7% | 0.00% | – |
| Q3 2020 | $24,000 | +9.1% | 3,123 | +4.6% | 0.00% | – |
| Q2 2020 | $22,000 | +2100.0% | 2,985 | +2002.1% | 0.00% | – |
| Q3 2019 | $1,000 | – | 142 | +14100.0% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 1 | -100.0% | 0.00% | – |
| Q1 2019 | $6,000 | +500.0% | 2,087 | +959.4% | 0.00% | – |
| Q4 2018 | $1,000 | -93.8% | 197 | -92.8% | 0.00% | – |
| Q3 2018 | $16,000 | +433.3% | 2,718 | +278.6% | 0.00% | – |
| Q2 2018 | $3,000 | -84.2% | 718 | -52.9% | 0.00% | – |
| Q1 2018 | $19,000 | – | 1,525 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 5AM Venture Management, LLC | 3,831,474 | $20,268,000 | 6.83% |
| AIGH Capital Management LLC | 637,322 | $3,372,000 | 1.37% |
| Worth Venture Partners, LLC | 162,875 | $862,000 | 0.68% |
| Ikarian Capital, LLC | 1,466,147 | $7,756,000 | 0.34% |
| RA Capital Management | 3,518,998 | $18,615,000 | 0.26% |
| Orbimed Advisors | 4,797,148 | $25,377,000 | 0.22% |
| DAFNA Capital Management LLC | 38,891 | $206,000 | 0.06% |
| BOOTHBAY FUND MANAGEMENT, LLC | 150,699 | $797,000 | 0.03% |
| Alyeska Investment Group, L.P. | 355,690 | $1,882,000 | 0.03% |
| ALGERT GLOBAL LLC | 13,860 | $73,000 | 0.02% |